Recently, our group showed the effect of SK2 inhibition in a psoriasis mouse model using the modestly potent SK2 inhibitor, ABC294640, which diminished Th17 differentiation of naïve CD4+ T cells with concomitant reduction in SOCS1 mRNA levels [21]. The gene discussed is SPHK2; the disease is psoriasis.